Cargando…
Atomoxetine as an Alternative Therapy for Adolescent Adhd With Comorbid Cerebral Palsy: A Case Report
AIMS: The prevalence of Attention Deficit Hyperactivity Disorder (ADHD) in children with Cerebral Palsy (CP) is 19%. Whilst there is evidence that methylphenidate is an efficacious first line therapy for patients with ADHD, there is a lack of literature describing atomoxetine use in ADHD with comorb...
Autores principales: | Calilung, Dominique, Yaman, Busra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345892/ http://dx.doi.org/10.1192/bjo.2023.361 |
Ejemplares similares
-
A critical appraisal of atomoxetine in the management of ADHD
por: Childress, Ann C
Publicado: (2015) -
Atomoxetine treatment and ADHD-related difficulties as assessed by adolescent patients, their parents and physicians
por: Dittmann, Ralf W, et al.
Publicado: (2009) -
Atomoxetine: a novel treatment for child and adult ADHD
por: Ledbetter, Marcialee
Publicado: (2006) -
Atomoxetine for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children with ADHD and dyslexia
por: Sumner, Calvin R, et al.
Publicado: (2009) -
Factors affecting treatment adherence to atomoxetine in ADHD: a systematic review
por: Treuer, Tamás, et al.
Publicado: (2016)